Stephen J. Russell, MD, PhD of Mayo Clinic discusses how viral therapy results will trigger a race to complete clinical trials. He states that there has been an increase in clinical trials due to viral therapy emerging as an important combination therapy in immunotherapy. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Viral Therapy Results Triggers Race to Complete Clinical Trials
